192 |
Bicuspid Valve Disease: Which Valve and How to Do? |
Sung Han Yoon |
Aug. 11. 17 |
191 |
TAVR of High-Risk/Complex Patients: For Whom and with? |
Eberhard Grube |
Aug. 11. 17 |
190 |
[Taped Case] TAVR with Evolut R |
Jung-Min Ahn |
Aug. 11. 17 |
189 |
[Taped Case] TAVR with Sapien |
Duk-Woo Park |
Aug. 11. 17 |
188 |
S3 in Challenging Anatomy, Implication in the Clinical Outcome |
Thierry Lefevre |
Apr. 21. 16 |
187 |
S3 in Transforming Patient Treatment Practice (Patient Selection, Length of Stay, etc.) |
Raj Makkar |
Apr. 21. 16 |
186 |
Sapien 3 Clinical Update |
Martin Bert Leon |
Apr. 21. 16 |
185 |
Sapien 3 Technology Overview |
Alain G. Cribier |
Apr. 21. 16 |
184 |
Extremely High Risk for TAVR - Insights from QOL and Cost-Effectiveness Studies |
David Joel Cohen |
Apr. 21. 16 |
183 |
TAVR for Bicuspid AS |
Sung Han Yoon |
Apr. 21. 16 |